[Impact of reslizumab on the course of chronic rhinosinusitis in patients with eosinophilic asthma].
N V BoykoO E LodochkinaM M KitV G KuleshovaN G NedashkovskayaPublished in: Vestnik otorinolaringologii (2021)
Treatment with reslizumab in patients with eosinophilic asthma and concomitant CRS with polyps and chronic non-allergic rhinitis (NARES) leads not only to improved control of asthma symptoms, but also to a significant regression of nasal symptoms.